Key Record Dates
ClinicalTrials.gov Identifier: | NCT04191135 |
---|---|
Brief Title: | Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009) |
First Submitted : | December 5, 2019 |
First Submitted that Met QC Criteria : | December 5, 2019 |
First Posted : | December 9, 2019 |
Last Update Submitted that Met QC Criteria : | June 3, 2022 |
Last Update Posted : | June 7, 2022 |